420 related articles for article (PubMed ID: 25427584)
41. Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.
Niu Q; Wang W; Li Y; Ruden DM; Wang F; Li Y; Wang F; Song J; Zheng K
PLoS One; 2012; 7(7):e41035. PubMed ID: 22844424
[TBL] [Abstract][Full Text] [Related]
42. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma.
Wang L; Lin N; Li Y
Oncol Rep; 2019 Mar; 41(3):1678-1690. PubMed ID: 30664164
[TBL] [Abstract][Full Text] [Related]
43. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
44. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
45. Hypericin affects cancer side populations via competitive inhibition of BCRP.
Vargová J; Mikeš J; Jendželovský R; Mikešová L; Kuchárová B; Čulka Ľ; Fedr R; Remšík J; Souček K; Kozubík A; Fedoročko P
Biomed Pharmacother; 2018 Mar; 99():511-522. PubMed ID: 29665654
[TBL] [Abstract][Full Text] [Related]
46. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
47. Tumor formation and drug resistance properties of human glioblastoma side population cells.
Chen D
Mol Med Rep; 2015 Jun; 11(6):4309-14. PubMed ID: 25633829
[TBL] [Abstract][Full Text] [Related]
48. Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.
Huang D; Gao Q; Guo L; Zhang C; Jiang W; Li H; Wang J; Han X; Shi Y; Lu SH
Stem Cells Dev; 2009 Apr; 18(3):465-73. PubMed ID: 18680391
[TBL] [Abstract][Full Text] [Related]
49. Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
Robey RW; Zhan Z; Piekarz RL; Kayastha GL; Fojo T; Bates SE
Clin Cancer Res; 2006 Mar; 12(5):1547-55. PubMed ID: 16533780
[TBL] [Abstract][Full Text] [Related]
50. Identification of a cancer stem-like population in the Lewis lung cancer cell line.
Zhang AM; Fan Y; Yao Q; Ma H; Lin S; Zhu CH; Wang XX; Liu J; Zhu B; Sun JG; Chen ZT
Asian Pac J Cancer Prev; 2012; 13(3):761-6. PubMed ID: 22631644
[TBL] [Abstract][Full Text] [Related]
51. Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling.
Hepburn AC; Veeratterapillay R; Williamson SC; El-Sherif A; Sahay N; Thomas HD; Mantilla A; Pickard RS; Robson CN; Heer R
PLoS One; 2012; 7(11):e50690. PubMed ID: 23226356
[TBL] [Abstract][Full Text] [Related]
52. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
[TBL] [Abstract][Full Text] [Related]
53. Sorting, identification and enrichment of side population cells in THP-1 acute monocytic leukemia cells.
Wang Y; Yin C; Feng L; Ma L; Wei Y; Sheng G
Oncol Rep; 2013 May; 29(5):1923-31. PubMed ID: 23450319
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a stem cell population in lung cancer A549 cells.
Sung JM; Cho HJ; Yi H; Lee CH; Kim HS; Kim DK; Abd El-Aty AM; Kim JS; Landowski CP; Hediger MA; Shin HC
Biochem Biophys Res Commun; 2008 Jun; 371(1):163-7. PubMed ID: 18423378
[TBL] [Abstract][Full Text] [Related]
55. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
[TBL] [Abstract][Full Text] [Related]
56. Detection of putative cancer stem cells of the side population phenotype in human tumor cell cultures.
Christgen M; Ballmaier M; Lehmann U; Kreipe H
Methods Mol Biol; 2012; 878():201-15. PubMed ID: 22674135
[TBL] [Abstract][Full Text] [Related]
57. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
58. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
59. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
[TBL] [Abstract][Full Text] [Related]
60. Detection and characterization of side population in Ewing's sarcoma SK-ES-1 cells in vitro.
Yang M; Zhang R; Yan M; Ye Z; Liang W; Luo Z
Biochem Biophys Res Commun; 2010 Jan; 391(1):1062-6. PubMed ID: 20004177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
